Vimarsana
Biggest News Aggregation in the World

Page 12 - Breakthrough Device News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Device Today - Breaking & Trending Today

magAssist Attended 2023 ISMCS to Showcase its Next-Gen Medical Solutions that Improve Treatment Outcomes of Critical Heart Diseases - Vimarsana News

magAssist Attended 2023 ISMCS to Showcase its Next-Gen Medical Solutions that Improve Treatment Outcomes of Critical Heart Diseases

/PRNewswire/ -- Earlier this month, magAssist Co.,Ltd. ("magAssist" and "the Company"), a leading medical developer of extracorporeal life support devices in...

Acrivon Announces Breakthrough Device Designation For ACR-368 OncoSignature Assay - Vimarsana News

Acrivon Announces Breakthrough Device Designation For ACR-368 OncoSignature Assay

Acrivon Therapeutics, Inc. (ACRV) announced the FDA has granted Breakthrough Device designation for the ACR-368 OncoSignature assay, a multiplex immunofluorescence assay for the identification of ovarian cancer patients who may benefit from ACR-368 treatment.

AWAK Technologies Announces FDA Breakthrough Device Designation for their Artificial Intelligence Enabled Kidney Disease Prediction Tool - Vimarsana News

AWAK Technologies Announces FDA Breakthrough Device Designation for their Artificial Intelligence Enabled Kidney Disease Prediction Tool

AWAK Technologies (AWAK), a pioneering medical technology company developing a wearable dialysis product and other complementary solutions for chronic kidney disease (CKD) management, today announced that its kidney disease progression prediction (KDPP) Artificial Intelligence (AI) model for CKD patient care has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA). The KDPP model helps to assess the risk of kidney disease progression and initiation of renal

Source: yahoo.com
NeuroEM Therapeutics Emerges from Chapter 11 with a Stronger Vision, ... - Vimarsana News

NeuroEM Therapeutics Emerges from Chapter 11 with a Stronger Vision, ...

NeuroEM Therapeutics Emerges from Chapter 11 with a Stronger Vision, ...

Auckland AI startup Toku Eyes wins spot on FDA fast-track approval programme in the US - Vimarsana News

Auckland AI startup Toku Eyes wins spot on FDA fast-track approval programme in the US

An Auckland medtech startup has won a rare spot on a programme that fast-tracks devices for regulatory approval in the US. Toku Eyes makes AI-powered...